Lung cancer mortality in European men

Trends and predictions

Matteo Malvezzi, Cristina Bosetti, Tiziana Rosso, Paola Bertuccio, Liliane Chatenoud, Fabio Levi, Canzio Romano, Eva Negri, Carlo La Vecchia

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Lung cancer mortality in men from the European Union (EU) peaked in the late 1980s at an age-standardised (world standard population) rate over 53/100,000 and declined subsequently to reach 44/100,000 in the early 2000s. To provide a comprehensive picture of recent trends in male lung cancer mortality in Europe, we analyzed available data from the World Health Organization up to 2009 and predicted future rates to 2015. Lung cancer mortality rates in EU men continued to fall over recent years, to reach a value of 41.1/100,000 in 2005-2009. The fall was similar at all-ages and in middle-aged men (less than 2% per year over most recent years), but was appreciably larger in young men (aged 20-44. years, over 5% per year). A favourable trend is thus likely to be maintained in the foreseeable future, although the predicted overall EU rate in 2015 is still over 35/100,000, i.e., higher than the US rate in 2007 (33.7/100,000). Over most recent calendar years, overall male lung cancer rates were around 35-40/100,000 in western Europe, as compared to over 50/100,000 in central and eastern Europe. Within western Europe, lung cancer rates were lower in northern countries such as Sweden, but also Finland and the UK (below 30/100,000), where the tobacco-related epidemic started earlier and rates have long been declining, whereas mortality was high in Belgium (51.6), France (42.3), the Netherlands and Spain (around 43.0), where the epidemic started later but is persisting. Widespread measures for smoking control and cessation in middle-aged European men, i.e., in the generations where smoking prevalence used to be high, would lead to appreciable reductions in male lung cancer mortality in the near future. This is particularly urgent in central and eastern European countries.

Original languageEnglish
Pages (from-to)138-145
Number of pages8
JournalLung Cancer
Volume80
Issue number2
DOIs
Publication statusPublished - May 2013

Fingerprint

Lung Neoplasms
Mortality
European Union
Eastern Europe
Belgium
Smoking Cessation
Finland
Sweden
Netherlands
Spain
France
Tobacco
Smoking
Population

Keywords

  • APC
  • Cancer
  • CIs
  • EAPC
  • EU
  • Europe
  • ICD
  • Lung
  • Male
  • Mortality
  • OR
  • PI
  • Projections
  • Trends
  • WHO

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Malvezzi, M., Bosetti, C., Rosso, T., Bertuccio, P., Chatenoud, L., Levi, F., ... La Vecchia, C. (2013). Lung cancer mortality in European men: Trends and predictions. Lung Cancer, 80(2), 138-145. https://doi.org/10.1016/j.lungcan.2013.01.020

Lung cancer mortality in European men : Trends and predictions. / Malvezzi, Matteo; Bosetti, Cristina; Rosso, Tiziana; Bertuccio, Paola; Chatenoud, Liliane; Levi, Fabio; Romano, Canzio; Negri, Eva; La Vecchia, Carlo.

In: Lung Cancer, Vol. 80, No. 2, 05.2013, p. 138-145.

Research output: Contribution to journalArticle

Malvezzi, M, Bosetti, C, Rosso, T, Bertuccio, P, Chatenoud, L, Levi, F, Romano, C, Negri, E & La Vecchia, C 2013, 'Lung cancer mortality in European men: Trends and predictions', Lung Cancer, vol. 80, no. 2, pp. 138-145. https://doi.org/10.1016/j.lungcan.2013.01.020
Malvezzi, Matteo ; Bosetti, Cristina ; Rosso, Tiziana ; Bertuccio, Paola ; Chatenoud, Liliane ; Levi, Fabio ; Romano, Canzio ; Negri, Eva ; La Vecchia, Carlo. / Lung cancer mortality in European men : Trends and predictions. In: Lung Cancer. 2013 ; Vol. 80, No. 2. pp. 138-145.
@article{0345bc6a34d547db932209382c0c1746,
title = "Lung cancer mortality in European men: Trends and predictions",
abstract = "Lung cancer mortality in men from the European Union (EU) peaked in the late 1980s at an age-standardised (world standard population) rate over 53/100,000 and declined subsequently to reach 44/100,000 in the early 2000s. To provide a comprehensive picture of recent trends in male lung cancer mortality in Europe, we analyzed available data from the World Health Organization up to 2009 and predicted future rates to 2015. Lung cancer mortality rates in EU men continued to fall over recent years, to reach a value of 41.1/100,000 in 2005-2009. The fall was similar at all-ages and in middle-aged men (less than 2{\%} per year over most recent years), but was appreciably larger in young men (aged 20-44. years, over 5{\%} per year). A favourable trend is thus likely to be maintained in the foreseeable future, although the predicted overall EU rate in 2015 is still over 35/100,000, i.e., higher than the US rate in 2007 (33.7/100,000). Over most recent calendar years, overall male lung cancer rates were around 35-40/100,000 in western Europe, as compared to over 50/100,000 in central and eastern Europe. Within western Europe, lung cancer rates were lower in northern countries such as Sweden, but also Finland and the UK (below 30/100,000), where the tobacco-related epidemic started earlier and rates have long been declining, whereas mortality was high in Belgium (51.6), France (42.3), the Netherlands and Spain (around 43.0), where the epidemic started later but is persisting. Widespread measures for smoking control and cessation in middle-aged European men, i.e., in the generations where smoking prevalence used to be high, would lead to appreciable reductions in male lung cancer mortality in the near future. This is particularly urgent in central and eastern European countries.",
keywords = "APC, Cancer, CIs, EAPC, EU, Europe, ICD, Lung, Male, Mortality, OR, PI, Projections, Trends, WHO",
author = "Matteo Malvezzi and Cristina Bosetti and Tiziana Rosso and Paola Bertuccio and Liliane Chatenoud and Fabio Levi and Canzio Romano and Eva Negri and {La Vecchia}, Carlo",
year = "2013",
month = "5",
doi = "10.1016/j.lungcan.2013.01.020",
language = "English",
volume = "80",
pages = "138--145",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Lung cancer mortality in European men

T2 - Trends and predictions

AU - Malvezzi, Matteo

AU - Bosetti, Cristina

AU - Rosso, Tiziana

AU - Bertuccio, Paola

AU - Chatenoud, Liliane

AU - Levi, Fabio

AU - Romano, Canzio

AU - Negri, Eva

AU - La Vecchia, Carlo

PY - 2013/5

Y1 - 2013/5

N2 - Lung cancer mortality in men from the European Union (EU) peaked in the late 1980s at an age-standardised (world standard population) rate over 53/100,000 and declined subsequently to reach 44/100,000 in the early 2000s. To provide a comprehensive picture of recent trends in male lung cancer mortality in Europe, we analyzed available data from the World Health Organization up to 2009 and predicted future rates to 2015. Lung cancer mortality rates in EU men continued to fall over recent years, to reach a value of 41.1/100,000 in 2005-2009. The fall was similar at all-ages and in middle-aged men (less than 2% per year over most recent years), but was appreciably larger in young men (aged 20-44. years, over 5% per year). A favourable trend is thus likely to be maintained in the foreseeable future, although the predicted overall EU rate in 2015 is still over 35/100,000, i.e., higher than the US rate in 2007 (33.7/100,000). Over most recent calendar years, overall male lung cancer rates were around 35-40/100,000 in western Europe, as compared to over 50/100,000 in central and eastern Europe. Within western Europe, lung cancer rates were lower in northern countries such as Sweden, but also Finland and the UK (below 30/100,000), where the tobacco-related epidemic started earlier and rates have long been declining, whereas mortality was high in Belgium (51.6), France (42.3), the Netherlands and Spain (around 43.0), where the epidemic started later but is persisting. Widespread measures for smoking control and cessation in middle-aged European men, i.e., in the generations where smoking prevalence used to be high, would lead to appreciable reductions in male lung cancer mortality in the near future. This is particularly urgent in central and eastern European countries.

AB - Lung cancer mortality in men from the European Union (EU) peaked in the late 1980s at an age-standardised (world standard population) rate over 53/100,000 and declined subsequently to reach 44/100,000 in the early 2000s. To provide a comprehensive picture of recent trends in male lung cancer mortality in Europe, we analyzed available data from the World Health Organization up to 2009 and predicted future rates to 2015. Lung cancer mortality rates in EU men continued to fall over recent years, to reach a value of 41.1/100,000 in 2005-2009. The fall was similar at all-ages and in middle-aged men (less than 2% per year over most recent years), but was appreciably larger in young men (aged 20-44. years, over 5% per year). A favourable trend is thus likely to be maintained in the foreseeable future, although the predicted overall EU rate in 2015 is still over 35/100,000, i.e., higher than the US rate in 2007 (33.7/100,000). Over most recent calendar years, overall male lung cancer rates were around 35-40/100,000 in western Europe, as compared to over 50/100,000 in central and eastern Europe. Within western Europe, lung cancer rates were lower in northern countries such as Sweden, but also Finland and the UK (below 30/100,000), where the tobacco-related epidemic started earlier and rates have long been declining, whereas mortality was high in Belgium (51.6), France (42.3), the Netherlands and Spain (around 43.0), where the epidemic started later but is persisting. Widespread measures for smoking control and cessation in middle-aged European men, i.e., in the generations where smoking prevalence used to be high, would lead to appreciable reductions in male lung cancer mortality in the near future. This is particularly urgent in central and eastern European countries.

KW - APC

KW - Cancer

KW - CIs

KW - EAPC

KW - EU

KW - Europe

KW - ICD

KW - Lung

KW - Male

KW - Mortality

KW - OR

KW - PI

KW - Projections

KW - Trends

KW - WHO

UR - http://www.scopus.com/inward/record.url?scp=84875895908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875895908&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2013.01.020

DO - 10.1016/j.lungcan.2013.01.020

M3 - Article

VL - 80

SP - 138

EP - 145

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -